carcinoma papilífero familiar de tireóide - Faculdade de Medicina ...

IX – REFERÊNCIAS BIBLIOGRÁFICAS
1. Vilar L. Endocrinologia clínica. 3.ed – Rio de Janeiro: Guanabara Koogan,
2006.
2. Loh KC. Familial nonmedullary thyroid carcinoma: a meta-review of case
series. Thyroid 1997; 7:107.
3. Takahashi M, Ritz J, Cooper GM. Activation of a novel human transforming
gene, ret, by DNA rearrangement. Cell 1985;42(2):581-8.3.
4. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, et al.
Germ-line mutations of the RET proto-oncogene in multiple endocrine
neoplasia type 2A. Nature 1993;363(6428):458-60.
5. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, et al.
Mutations in the RET proto-oncogene are associated with MEN 2A and
FMTC. Hum Mol Genet 1993;2(7):851-6.
6. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, et
al. A mutation in the RET proto-oncogene associated with multiple endocrine
neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature
1994;367(6461):375-6.
7. Santoro M, Carlomagno F, Melillo RM, Billaud M, Vecchio G, Fusco A.
Molecular mechanisms of RET activation in human neoplasia. J Endocrinol
Invest 1999;22(10):811-9.
8. Robinson DW, Orr TG. Carcinoma of the thyroid and other diseases of the
thyroid in identical twins. A.M.A. Arch. Surg. 1955;70:923–928
9. Pal T, Vogl FD, Chappuis PO, et al. Increased risk for nonmedullary thyroid
cancer in the first degree relatives of prevalent cases of nonmedullary
59